Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5262 | Biocybernetics and Biomedical Engineering | 2011 | 9 Pages |
Abstract
A group of 37 patients diagnosed with Parkinson’s disease (PD) were treated with subthalamic deep brain stimulation (STN DBS). The mean age at implantation was 59±11 years and PD has been present from 6 to 17 years (mean 9). The STN was identified by direct and indirect methods: macro stimulation and microrecording in all cases. At a three month follow-up, the authors observed a mean reduction of 49% in UPDRS II score and a mean reduction of 65% in UPDRS III score. Mean reduction of l-dopa consumption was 62%. The authors concluded that STN DBS safely reduces disabling symptoms of PD.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Tomasz Mandat, Henryk Koziara, Paweł Nauman, Tomasz Tykocki, Wiesław Bonicki,